Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CABOZANTINIB vs CALASPARGASE PEGOL: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

CABOZANTINIB vs CALASPARGASE PEGOL: Safety Overview

Metric CABOZANTINIB CALASPARGASE PEGOL
Total FAERS Reports 3,831 125
Deaths Reported 767 22
Death Rate 20.0% 17.6%
Hospitalizations 2,771 79
Average Patient Age 62.2 yrs 11.3 yrs
% Female Patients 27.5% 50.0%
Manufacturer N/A Servier Pharmaceuticals LLC
Route N/A INTRAVENOUS
Marketing Status None N/A